UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41923
EUPRAXIA PHARMACEUTICALS INC.(Exact name of Registrant as specified in its charter)
N/A(Translation of Registrant’s name)
2198 Yukon StreetVancouver, British Columbia, Canada V5Y 3P1Telephone: (250) 590-3968 (Address and... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-39601
MINISO Group Holding Limited
8F, M Plaza, No. 109, Pazhou Avenue
Haizhu District, Guangzhou 510000, Guangdong Province
The People’s Republic of... (continue reading...)
Filed Pursuant to Rule 424(b)(3)Registration No. 333-279329
Prospectus Supplement No. 32
(to prospectus dated June 5, 2024)
44,382 Shares of Common Stock
This prospectus supplement amends and supplements the prospectus of Longevity Health Holdings, Inc. (“we,” “us,” or “our”) dated June 5, 2024 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our Registration Statement on... (continue reading...)
More SEC Filings
View Older Stories-
Form 485BXT J.P. Morgan Exchange-Tra
-
Form 8-K Spyre Therapeutics, Inc. For: Sep 08
-
Form 6-K CRESUD INC For: Sep 07
-
Form 8-K Arrive AI Inc. For: Sep 04
-
Form 8-K 1606 CORP. For: Sep 08
-
Form 8-K RELMADA THERAPEUTICS, For: Sep 03
-
Form 6-K GILAT SATELLITE NETWORKS For: Sep 08
-
Form PRE 14A Trade Desk, Inc. For: Oct 19
-
Form DEFA14A HeartSciences Inc.
-
Form 6-K Garden Stage Ltd For: Sep 08
-
Form 8-K Strategy Inc For: Aug 31
-
Form 6-K Adlai Nortye Group Ltd. For: Sep 08
-
Form 8-K Sana Biotechnology, Inc. For: Sep 08
-
Form 8-K Definium Therapeutics, For: Sep 08
-
Form 8-K Longevity Health Holding For: Sep 08
-
Form 6-K LOGPROSTYLE INC. For: Sep 08
-
Form 424B3 JONES FINANCIAL COMPANIE
-
Form 6-K Swvl Holdings Corp For: Sep 08
-
Form 8-K Strive, Inc. For: Sep 08
-
Form D Gaingels Kepler Labs
-
Form 424B2 MERCADOLIBRE INC
-
Form 424B5 SMITH & NEPHEW PLC
-
Form 15-12G LEGGETT & PLATT INC
-
Form 424B5 BANK OF MONTREAL /CAN/
-
Form 6-K SuperX AI Technology For: Sep 08
-
Form 424B3 Longevity Health Holding
-
Form 6-K GENMAB A/S For: Sep 08
-
Form 8-K GENERAL ELECTRIC CO For: Sep 08
-
Form 15-12G LEGGETT & PLATT INC
-
Form 6-K Clearmind Medicine Inc. For: Sep 08
-
Form 497K Tidal Trust II
-
Form 4 Pyxis Oncology, Inc. For: Sep 04 Filed by: Civik Thomas
-
Form 8-K GROUP 1 AUTOMOTIVE INC For: Sep 08
-
Form 8-K IonQ, Inc. For: Sep 08
-
Form SCHEDULE 13G/A TPG Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A AAON, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Zenas BioPharma, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form 8-K Pyxis Oncology, Inc. For: Sep 03
-
Form D 1789 Capital Fund II-B,
-
Form 8-K NABORS INDUSTRIES LTD For: Sep 08
-
Form 8-K Philip Morris Internatio For: Sep 08
-
Form 10-Q enGene Therapeutics Inc. For: Jul 31
-
Form D 1789 US Feeder II-A, LP
-
Form 4 SCHMID Group N.V. For: May 23 Filed by: Speth Ralf
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Greenberg Aaron Samuel
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Furman Carly Lisanne
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Sever Michal
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Manor Sagit
-
Form 4 ZIM Integrated Shipping For: Sep 04 Filed by: Meyer-Gloeckner Birger Johannes
-
Form N-CSRS ABERDEEN INDIA FUND, For: Jun 30

